OMA BOT Book 4.24.2024

OMA 2024

OMA Board of Trustees Meeting Book let

April 2 4 , 2024 CONFIDENTIAL CONTENT – DO NOT SHARE CONTENT S OUTSIDE OMA

Board of Trustees (BOT) Meeting 04/24/2024 1:00--5:00 PM MDT Hyatt Regency Denver At Colorado Convention Center Granite Conference Room, 3 rd Floor Denver, CO

Zoom Information: https://obesitymedicine-org.zoom.us/j/88370028214?pwd=aXpJjTg26bmJFy1flfIVJCddoGzbKM.1 Meeting ID: 883 7002 8214 Passcode: 843002 Dial-In Information: 719-359-4580; 88370028214#

Presiding Officer: Dr. Angela Fitch

Time

Topic

Lead Fitch

Action

Page

1:00 PM

Call to Order and Opening Remarks

1:02 PM

Roll Call

Censani

1:04 PM 1:05 PM

Approval of the Agenda

Fitch Fitch

Vote

2 - 3

Conflict of Interest Disclosures

Discussion

4 – 13

1:08 PM

Approval of the Consent Agenda and Supporting Documents Welcome to the New BOT Members to be Installed on 4/27/2024: • Dr. Courtney Younglove • Karlijn Burridge, PA-C • Dr. Christopher Weber ( Not present- moderating ABOM Review Course ) Obesity Action Coalition (OAC) Board Representation from OMA’s BOT Appointment of the Ex-Officio Member to the OMA’s BOT

Fitch

Vote

14 - 32

1:10 PM

Fitch

Information

1:15 PM

Fitch

Information

1:20 PM

Fitch

Vote

1:35 PM

Updates from Obesity Pillars

Bays

Information

33 - 35

1:55 PM

AMA Delegate Seat Discussion Items:

Lazarus, Fitch

Discussion and Vote

36 - 50

1. Updates from the AMA 2. Recommendation and Appointment of the AMA Alternate Delegate

3. Motion re: Recognition of the role of the AMA Delegate at the BOT Level 4. OMA + AMA Membership Recruitment Strategy and Options Motion re: Proposed Language Edits to the COI Policy Utilization of Obesity Treatment Foundation (OTF) Funds for OM Standards of Care Development (or other) Purposes Motion re: Grant Funding for Obesity Related Publications in Obesity Pillars Compounding Peptides: An OMA Position Statement and ( Potential) Need for Updates to This Statement Break

2:40 PM

Bays

Discussion, Vote

51 - 57

3:00 PM

3:20 PM

Fitch

Discussion, Vote

58 - 77

3:50 PM

Fitch, Bays

Discussion, Vote

4:05 PM

Fitch

Discussion, Vote

78 - 81

4:20 PM

OMA Committee Membership Expectations

Fitch

Discussion

82 - 96

4:35 PM

Treat or Refer Updates

Fraker

Information

4:40 PM

Onboard IT platform for OMA BOT Related Work BOT Installation of Officers and Awards Ceremony Run of Show Details

Fraker

Information

4:45 PM

Fraker

Information

4:50 PM

New Business, Items for Generative Discussion, Etc. Call to Adjourn and Closing Remarks

Fitch

5:00 PM

Fitch

Conflict of Interest Policy and Disclosure Statement

OMA Conflict of Interest Policy The Obesity Medicine Association (OMA) Board of Trustees must act at all times in the best interest of OMA. The purpose of this policy is to help inform the OMA, its members and leaders about what constitutes a conflict of interest, provide assistance in identification and disclosure of actual and potential conflicts, and help ensure the avoidance and resolution of conflicts of interest when necessary. This policy may be enforced as described below: 1. Board members have a fiduciary duty to conduct themselves without conflict to the interests of OMA. In these capacities, they must subordinate personal, individual business, third-party and other interests to the welfare and best interests of OMA. 2. A conflict of interest is a transaction or relationship which presents or may present a conflict between an individual’s obligations to OMA and the individual’s personal, business or other interests. a. Generally, a conflict of interest could be said to exist when individuals have material interests outside OMA which could influence them, or could be perceived as influencing them to act contrary to the best interests of OMA and for their own personal benefit or the benefit of a relative or business associate. If such conflict is identified, the individual is asked to extract themselves from voting on a motion. b. Frequently the type of interest resulting in a conflict would be financial, such as an individual who has an association with a third party through ownership interest, stock/bond holdings, a grant, an employment relationship, or a consultative or advisory arrangement. Examples include serving on a speakers’ bureau or advisory board, as well as receiving honoraria from a medical education company for CME presentations. NOTE: An individual’s employment by a pharmaceutical company involved in obesity, medical device company involved in obesity, supplement or food company involved in weight loss products, or other companies that could have the appearance of having a conflict of interest with OMA as determined from time to time by the OMA Board of Trustees are deemed to be direct conflicts of interest that would preclude the individual from serving as a member of the OMA Board of Trustees. c. In some instances a conflict of interest may exist even though the conflict does not arise out of financial considerations. For example, a member of the OMA Board of Trustees also may have a fiduciary responsibility as a member of the Board of Trustees or committee of another organization. If the interests of that organization were contrary to or in competition with the interests of OMA, a situation could exist in which the individual could not fulfill his or her fiduciary responsibilities to both organizations or may be disqualified as a board of trustee candidate during the nomination process. 3. All conflicts of interest are not necessarily prohibited or harmful to the OMA. However, full disclosure of all actual and potential conflicts, and a determination by the Board – with the interested individual recused from participating in debates and voting on the matter – are required. NOTE: some conflicts may lead to a disqualification during candidacy as determined by the OMA Nominating Committee. 4. All actual and potential conflicts of interest shall be disclosed by Board members through the annual disclosure statement and/or whenever a conflict arises. The disinterested members of the Board shall make a determination as to whether a conflict exists and what subsequent action is appropriate (i.e. require the person with the conflict to abstain from discussing or voting on matters involving the conflict, resign from office, etc.). 5. On an annual basis, all Board members shall be provided with a copy of this policy and are required to complete and sign the disclosure statement below. OMA will provide all members of the Board with copies of the disclosure statements for all members of the Board and will publicly list potential conflicts as part of the candidacy announcement. Note: A separate policy exists for all OMA Continuing Medical Education activities. Individuals participating in these activities are subject to the “OMA Policy for Commercial Support and Continuing Education Programs” and should complete the full disclosure statement developed solely for these activities.

Disclosure Statement I have read the OMA conflict of interest policy set forth above and agree to comply fully with its terms and conditions at all times during my service to OMA. If at any time following submission of this form I become aware of any actual or potential conflicts of interest, or if the information provided below becomes inaccurate or incomplete, I will promptly notify the OMA Executive Director in writing. I understand that if I indicate a financial or other relationship or interest below, that information will be reviewed to determine whether this relationship precludes my participation on the Board. I understand that failure or refusal to disclose, false disclosure, or inability to resolve conflicts of interest will disqualify me from participating on the Board immediately. I agree that as an OMA Board of Trustee member I will make every effort that all my Association related activities and votes will be solely in the best interest of the OMA.

Disclosure of Actual or Potential Conflicts of Interest occurring within 1 year of the date of this form and within the foreseeable future:

Disclosure of ANY interests that could possibly result in a Conflict of Interest in the future with OMA, such as an ownership interest in any business, stock/bond holdings, a grant, an employment relationship, or consultative or advisory arrangement, etc.:

Disclosure of involvement / relationships with other similar or competitive associations / societies which represent interests of obesity medicine clinicians (please specify your level of involvement, i.e. board member, committee leader, committee member, general member, etc.):

Signature

Print Name

Date

Product

Company

Description

Type

Relationship

Board Member

CinRX is a biotech company founded in 2015 that is focused on the drug development sector.

Angela Fitch

Pharmaceuticals

CinRX

Pharmaceutical

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Advisory Board & Speakers Bureau

Pharmaceutical

Eli Lilly

Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients. Knownwell Inc. is a healthcare delivery company Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Sidekick is a social health game. It is designed to motivate and engage people towards a healthy lifestyle. Sidekick allows people to communicate, collaborate and compete with friends and colleagues, while improving their lifestyle. Suvie builds a multi-zone cool to cook kitchen robot that makes 5 star meals with zero effort. Ms.Medicine is an innovative health care organization whose mission is to raise the standard of care of women’s health. Diet Program

Biotechnology, Medical Device, diabetes

Pharmaceuticals

Gelesis

Advisory Board

Pharmaceuticals

Knownwell Inc.

Biotechnology

Stock Ownership

Pharmaceuticals

Merck

Biotechnology, pharmaceutical Editor

Pharmaceuticals

NovoNordisk

Biotechnology, pharmaceutical Advisory Board

Biotechnology

Sidekick Health

Behavior App

Nutrition

Jenny Craig

Food and beverage

Science Advisory Board

Nutrition

Suvie

Food and beverage

Advisor

Turn-Key Business Solutions MsMedicine

Health Care

Advisory Board

FoundHealth.com offers information to help patients discover a range of treatments for their health challenges Health Care

Turn-Key Business Solutions Found Health

Advisory Board

This course covers critical topics in the prevention and treatment of obesity and related disorders presented by authorities from the country’s leading obesity treatment centers.

Harvard Blackburn Obesity Medicine

Education

Education

Co-Director

The American College of Physicians (ACP) is a national organization of internists, who specialize in the diagnosis, treatment, and care of adults Association

501C-6 / 501C-3 Organizations

American College of Physicians (ACP)

Member

The American Society for Metabolic and Bariatric Surgery (ASMBS) is the largest national society for this specialty. The vision of the Society is to improve public health and well being by lessening the burden of the disease of obesity and related diseases throughout the world. The Obesity Society (TOS) is the leading scientific society dedicated to the study of obesity.

American Society of Metabolic and Bariatric Surgery (ASMBS)

501C-6 / 501C-3 Organizations 501C-6 / 501C-3 Organizations

Association

Member

General Member, planning committee

The Obesity Society (TOS)

Association

Product

Company

Company Description

Type

Relationship

Board Member

Currax Pharmaceuticals LLC is a patient-first pharmaceutical company focused on the number one and number two preventable deaths in the United States: smoking addiction and obesity.

Ethan Lazarus

Pharmaceutical

Currax

Pharmaceutical

Speaker, Advisory Board

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Speaker, Advisory Board (May 18th and 19th 2023 for advisory board)

Pharmaceutical

Eli Lilly

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company committed to transforming the care for patients living with rare genetic diseases of obesity. Nestlé Health Science is a leader in the field of nutritional science, committed to redefining the management of health. We offer an extensive portfolio of science-based consumer health, medical nutrition and supplement brands. This course covers critical topics in the prevention and treatment of obesity and related disorders presented by authorities from the country’s leading obesity treatment centers. The American Academy of Family Physicians (AAFP) was founded in 1947 to promote and maintain high quality standards for family medicine, an offshoot of the classical general practitioner. The American Medical Association (AMA) is an organization of American physicians, the objective of which is “to promote the science and art of medicine and the betterment of public health.”

Pharmaceutical

NovoNordisk

Biotechnology, pharmaceutical Speakers Bureau

Consultant in development of hyperphagia assessment tool

Pharmaceutical

Rhythm Pharmaceuticals

Biotechnology, pharmaceutical

Nutrition

Nestle Nutrition

Food and beverage

Advisory Board/Speaker

Harvard Blackburn Obesity Medicine

Education

Education

Presenter

501C-6 / 501C-3 Organizations

American Academy of Family Physicians

Association

Member

501C-6 / 501C-3 Organizations

American Medical Association (AMA)

Association

Member, Delegate for OMA

The Colorado Medical Society (CMS) is the largest group of organized physicians in Colorado. This nonprofit organization is

composed of physicians, residents and medical students. It was founded in 1871 to promote the art and science of medicine and to improve public health. Association

501C-6 / 501C-3 Organizations

Colorado Medical Society

Member

Boehringer Ingelheim is a pharmaceutical company that develops innovative healthcare products for both human & animal needs. Redesign Health Inc. operates as a health care company. The Company focuses on developing technologies, tools, and insights to improve surgical outcomes for patients, as well as co

Biotechnology, Medical, Pharma ceutical

Pharmaceuticals

Boehringer Ingelheim

Advisory Board

develop, launch, and scale new businesses that tackle the most pressing issues in healthcare.

Healthcare Technology

Redesign Health

Biotechnology, Medical

Advisory Board

Product

Company

Type

Relationship

Board Member

Company Description

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Lydia Alexander

Pharmaceutical

Eli Lilly

Speakers Bureau

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This course covers critical topics in the prevention and treatment of obesity and related disorders presented by authorities from the country’s leading obesity treatment centers. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The American Medical Association (AMA) is an organization of American physicians, the objective of which is “to promote the science and art of medicine and the betterment of public health.” The Obesity Society (TOS) is the leading scientific society dedicated to the study of obesity. The American College of Lifestyle Medicine (ACLM) is the medical professional society providing quality education and certification to those dedicated to clinical and worksite practice of lifestyle medicine as the foundation of a transformed and sustainable health care system. Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. Enara Health is a holistic weight management platform that is building an expansive healthcare network to scale medical obesity treatment. 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Allergan plc is an American, Irish domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. Medical devices in major areas (e.g. cardiovascular, neurology, orthopedic) Minimally invasive – surgery technologies including robotics and tracking Medical equipment: therapeutic and diagnostic Health and personal Care products Medical IT and healthcare web applications Aesthetic-medical technologies Altimmune is a clinical-stage biopharmaceutical company focused on the development of novel peptide based therapeutics for the treatment of obesity and liver diseases. Company Description

Pharmaceuticals

NovoNordisk

Biotechnology, pharmaceutical Advisory Board

Harvard Blackburn Obesity Medicine

Obesity Medicine Course Lecturer

Education

Education

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Pharmaceutical

Eli Lilly

Speakers Bureau

SELECT Obesity National Advisory Board

Pharmaceuticals

NovoNordisk

Biotechnology, pharmaceutical

501C-6 / 501C-3 Organizations 501C-6 / 501C-3 Organizations

American Medical Association (AMA)

Association

Member

The Obesity Society (TOS)

Association

Member

The American College of Physicians (ACP) is a national organization of internists, who specialize in the diagnosis, treatment, and care of adults Association

501C-6 / 501C-3 Organizations

American College of Physicians (ACP)

Member

501C-6 / 501C-3 Organizations

American College of Lifestyle Medicine

Association

Member

Surgical

Intuitive Surgical

Corporation

Consultant

Biotechnology

Enara Health

Biotechnology platform

Stock Ownership

Product

Company

Type

Relationship

Board Member

Received Grant, Consultant/Advisor

Harold Bays

Pharmaceuticals

89Bio

Biopharmaceutical

Pharmaceuticals

Allergan

Pharmaceutical

Received Grant

Pharmaceuticals

Alon Medteck/Epitomee

Devices, therapeutics

Received Grant

Received Grant, Consultant/Advisor

Pharmaceuticals

Altimmune

Biopharmaceutical

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California Anji Pharma is a clinical-stage biotech company with operations in the U.S., Beijing, and Shanghai. AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines. Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Biohaven is a clinical-stage biopharmaceutical company with proven leadership in industry and academic settings. Bionime was established in April 2003 with the goal of improving the lives of people with diabetes through better self-monitoring. Bionime is focused on designing and manufacturing accurate medical testing equipment. Boehringer Ingelheim is a pharmaceutical company that develops innovative healthcare products for both human & animal needs. CinCor is a clinical-stage biopharmaceutical company targeting cardiovascular, metabolic and kidney diseases CSL Behring is a biopharmaceutical company, manufacturing plasma derived and recombinant therapeutic products Esperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. Evidera provides evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products A metabolic therapeutics company focused on pioneering new approaches for the treatment of metabolic diseases, including type 2 diabetes and obesity. Their goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of T2D and obesity. Gan & Lee Pharmaceuticals is a leading pharmaceutical company in China specializing in the development, production, and commercialization of recombinant insulin analogs and injection pens,* with plans to expand globally. Kallyope, Inc. is a leading biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis. Madrigal is a clinical-stage biopharmaceutical company pursuing novel therapeutics for fatty liver diseases. Matinas Biopharma Holdings, Inc. is a biopharmaceutical company. The Company is focused on redefining the intracellular delivery of nucleic acids and small molecules through its lipid nanocrystal (LNC) drug delivery platform. Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. NewAmsterdam Pharma is a clinical stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

Received Grant, Consultant/Advisor

Pharmaceuticals

Amgen

Biopharmaceutical

Pharmaceuticals

Anji Pharma

Biotech

Received Grant

Pharmaceuticals

AstraZeneca

Biopharmaceutical

Received Grant

Pharmaceuticals

Axsome

Biopharmaceutical

Received Grant

Pharmaceuticals

BioHaven

Biopharmaceutical

Received Grant

Pharmaceuticals

Bionime

Biotechnology

Received Grant

Biotechnology, Medical, Pharma ceutical

Received Grant, Consultant/advisor

Pharmaceuticals

Boehringer Ingelheim

Pharmaceutical

CinCor

Biopharmaceutical

Received Grant

Pharmaceutical

CSL Behring

Biopharmaceutical

Received Grant

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Received Grant, Consultant/advisor

Pharmaceutical

Eli Lilly

Received Grant, Consultant/Advisor

Pharmaceutical

Esperion

Pharmaceutical

Biopharmaceutical, biotechnology

Pharmaceutical

Evidera

Received Grant

Biopharmaceutical, biotechnology

Fractyl

Received Grant

Biotechnology

Pharmaceutical

Gan and Lee

Pharmaceutical

Received Grant

Biotechnology

Biotechnology

Received Grant

Kallyope

Pharmaceutical

Madrigal

Biopharmaceutical

Received Grant

Pharmaceutical

Matinas

Biopharmaceutical

Received Grant

Pharmaceutical

Merck

Biotechnology, pharmaceutical Received Grant

Pharmaceutical

New Amsterdam

Pharmaceutical

Received Grant

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. Pharmaceutical

Pharmaceutical

Novartis

Received Grant

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Pfizer is a pharmaceuticals and biotechnology company.

Pharmaceutical

NovoNordisk

Biotechnology, pharmaceutical Received Grant

Pharmaceutical

Pfizer

Biotechnology, pharmaceutical Received Grant

Regerenron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. We are a clinical-stage biopharmaceutical company dedicated to bringing novel treatments to people who suffer from migraine and other debilitating conditions. Selecta Biosciences is a clinical stage biotechnology company with a commitment to solving the challenges associated with autoimmunity and unwanted immunogenicity through our pioneering ImmTOR® precision immune tolerance platform. Shionogi Inc. is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs. a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health. Metavante Technologies, Inc., through its subsidiary, Metavante Corporation, provided financial technology services, software and financial services regulatory advice and consulting to its customers, consisting primarily of small to large sized financial institutions. An Academic Research Organization of Brigham & Women's Hospital and An Affiliate of Harvard Medical School The Obesity Society (TOS) is the leading scientific society dedicated to the study of obesity. The ASPC, founded in 1985, represents a multidisciplinary group of healthcare practitioners and researchers who share an interest in and a passion for preventive cardiology. Endocrine Society is a global community of endocrine investigators and clinicians focused on improving patient care, advancing research, shaping effective policy, and ensuring the future of endocrinology. The American College of Cardiology, a 49,000-member nonprofit medical society, enhances the lives of cardiovascular patients through continuous quality improvement, patient-centered care, payment innovation, and professionalism. The ADA's mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. The National Lipid Association is a 501(c)(3) organization formed in 2008 to serve as a patient education organization in the field of clinical lipidology. The American Medical Association (AMA) is an organization of American physicians, the objective of which is “to promote the science and art of medicine and the betterment of public health.” World Obesity Federation is a membership organisation representing national and regional associations dedicated to the study and management of obesity and related comorbidities. This course covers critical topics in the prevention and treatment of obesity and related disorders presented by authorities from the country’s leading obesity treatment centers. An annual symposium, in honor of George A Bray MD, preeminent obesity experts from PBRC and around the US will elucidate the latest advances in the pathophysiology of obesity as well as advances in multidisciplinary obesity treatment. Home Access Health Corporation, which is now a subsidiary of Everly Practice Management Software

Pharmaceutical

Regerenron

Biotechnology

Received Grant

Pharmaceutical

Sanofi

Pharmaceutical

Received Grant

Pharmaceutical

Satsuma

Biopharmaceutical

Received Grant

Pharmaceutical

Selecta

Biotechnology

Received Grant

Pharmaceutical

Shionogi

Pharmaceutical company

Received Grant

Biopharmaceutical

Viking

Biopharmaceutical company Received Grant

Pharmaceutical

Vivus

Biopharmaceutical

Received Grant

Health, was founded to provide customers with health information through simple, self-collected lab tests Health Care

Laboratory Testing Legal Technology

Home Access

Received Grant Received Grant

Lexicon

Legal Technology

Business Tools

Received Grant

Technology

Metavant

501C-6 / 501C-3 Organizations 501C-6 / 501C-3 Organizations

TIMI

Education

Received Grant

General Member, Fellow, Speaker

The Obesity Society (TOS)

Association

The American Society of Preventative Cardiology (ASPC)

501C-6 / 501C-3 Organizations

Association

Board Member, Fellow, Speaker

501C-6 / 501C-3 Organizations

The Endocrine Society

Association

Member

AACE is the organization focused on endocrinology, diabetes and metabolism that is most: Recognized worldwide for its clinical leadership Association

American Association of Clinical Endocrinologists (AACE)

501C-6 / 501C-3 Organizations

Member

501C-6 / 501C-3 Organizations 501C-6 / 501C-3 Organizations

American College of Cardiology (ACC)

Association

Member, Fellow, Speaker

American Diabetes Association (ADA)

Association

Member

501C-6 / 501C-3 Organizations

The National Lipid Association

Association

Producing a Joint Statement

501C-6 / 501C-3 Organizations

American Medical Association (AMA)

Association

Member

501C-6 / 501C-3 Organizations

World Obesity Federation

Association

Member

Harvard Blackburn Obesity Medicine

Education

Education

Speaker

Bray Obesity Science Symposium (BOSS)

Education

Speaker

Education

Product

Company

Type

Relationship

Board Member

Company Description

Endocrine Society is a global community of endocrine investigators and clinicians focused on improving patient care, advancing research, shaping effective policy, and ensuring the future of endocrinology. The Pediatric Endocrine Society invites members to form Special Interest Groups (SIGs). SIGs provide a venue for members to network with other colleagues sharing similar interests, to provide a forum to discuss issues concerning topics relevant to the SIGs, and work towards goals that will benefit our patients and the membership of the Pediatric Endocrine Society at large. Currax Pharmaceuticals LLC is a patient-first pharmaceutical company focused on the number one and number two preventable deaths in the United States: smoking addiction and obesity. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Phenomix is a drug discovery and development company building a portfolio of novel therapeutics for the treatment of major human diseases VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health. Nestlé Health Science is a leader in the field of nutritional science, committed to redefining the management of health. We offer an extensive portfolio of science-based consumer health, medical nutrition and supplement brands. Illinois Obesity Society is a group of health care professionals dedicated to improving the treatment of Obesity in Illinois. Company Description

501C-6 / 501C-3 Organization+A69s

Marisa Censani

The Endocrine Society

Association

Member

501C-6 / 501C-3 Organization+A69s

Pediatric Endocrine Society (SIG)

Member, completed a three-year term as co-chair

Association

Product

Company

Type

Relationship

Board Member

Anthony Auriemma

Pharmaceuticals

Currax

Pharmaceutical

Speakers Bureau

Pharmaceuticals

NovoNordisk

Biotechnology, pharmaceutical Speakers Bureau

Pharmaceuticals

Phenomix

Biotechnology, pharmaceutical Consulting

Pharmaceuticals

Vivus

Biopharmaceutical

Speaker Bureau

Nutrition

Nestle Nutrition

Food and beverage

Consulting

501C-6 / 501C-3 Organizations

Illinois Obesity Society

Association

Board of Trustee Member

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Pharmaceutical

Eli Lilly

Speakers Bureau

Product

Company

Type

Relationship

Board Member

Company Description

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Sandra Christensen

Pharmaceuticals

Eli Lilly

Advisory Board

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.

Pharmaceuticals

NovoNordisk

Biotechnology, pharmaceutical Speakers Bureau

The Washington Obesity Society is a coalition dedicated to creating a community resource for providers in the growing field of obesity medicine. Association

501C-6 / 501C-3 Organization+A69s

Washington Obesity Society

Trustee

AANP empowers all NPs to advance accessible, person-centered, equitable, high-quality health care for diverse communities through practice, education, advocacy, research and leadership.

501C-6 / 501C-3 Organization+A69s

the American Association of Nurse Practitioners (AANP).

Association

Member, speaker

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Pharmaceutical

Eli Lilly

Speaker

Abbott Laboratories is an American multinational medical devices and health care company. AANP is the largest and only full service national professional membership organization for NPs of all specialties. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company committed to transforming the care for patients living with rare genetic diseases of obesity. The American Academy of Pediatrics (AAP) and its member pediatricians dedicate their efforts and resources to the health, safety and well-being of infants, children, adolescents and young adults. The Obesity Society (TOS) is the leading scientific society dedicated to the study of obesity. Company Description

Technology

Abbott Laboratories

Medical Device Company

Advisory Board

American Association of Nurse Practitioners

Professional Organization

Association

Education Planner and Fellow

Product

Company

Type

Relationship

Board Member

Suzanne Cuda

Pharmaceutical

NovoNordisk

Biotechnology, pharmaceutical Advisory Board

Pharmaceutical

Rhythm Pharmaceuticals

Biotechnology, pharmaceutical Gold Faculty

501C-6 / 501C-3 Organization+A69s 501C-6 / 501C-3 Organization+A69s

American Academy of Pediatrics

Association

Member

The Obesity Society (TOS)

Association

General Member

Product

Company

Type

Relationship

Board Member

Company Description

Course and consulting business to help physicians start obesity medicine practices

Carolynn Francavilla Brown Education

Weight Care Consulting

Health Care

Owner

The American Medical Association (AMA) is an organization of American physicians, the objective of which is “to promote the science and art of medicine and the betterment of public health.”

501C-6 / 501C-3 Organization+A69s

American Medical Association (AMA)

Governing Council for private practice physicians

Association

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Pharmaceutical

Eli Lilly

Speakers Bureau

Product

Company

Type

Relationship

Board Member Michelle Freshwater

Company Description

Product

Company

Type

Relationship

Board Member

Company Description

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Product sales in obesity medicine practice Physicians.com strives to improve the quality of life through routine and affordable telemedical care with increased accessibility to pharmacutucal drugs by providing quality products at the most affordable price.

Sylvia Gonsahn-Bollie

Pharmaceuticals

NovoNordisk

Biotechnology, pharmaceutical Consulting

Education

Shaklee Corporation

Health Care

Ambassador

Healthcare

Physicians.com

Health Care

Medical Director

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Executive Director of Clinical Research in obesity

Pharmaceutical

Eli Lilly

Product

Company

Type

Relationship

Board Member

Company Description

The Obesity Society (TOS) is the leading scientific society dedicated to the study of obesity.

501C-6 / 501C-3 Organizations

Bharti K. Shetye

The Obesity Society (TOS)

Association

Member

c

The American Society for Metabolic & Bariatric Surgery is a non-profit medical organization dedicated to metabolic and bariatric surgery, and obesity-related diseases and conditions Association

American Society for Metabolic & Bariatric Surgery (ASMBS)

501C-6 / 501C-3 Organizations

Member

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.

Pharmaceuticals

NovoNordisk

Biotechnology, pharmaceutical Consultant Agreement

Product

Company

Type

Relationship

Board Member

Company Description

Currax Pharmaceuticals LLC is a patient-first pharmaceutical company focused on the number one and number two preventable deaths in the United States: smoking addiction and obesity. Phenomix is a drug discovery and development company building a portfolio of novel therapeutics for the treatment of major human diseases. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Medical educational company The American Medical Association (AMA) is an organization of American physicians, the objective of which is “to promote the science and art of medicine and the betterment of public health.” Hims & Hers Health, Inc. is an American telehealth company that sells prescription and over-the-counter drugs online, as well as personal care products

Craig Primack

Pharmaceuticals

Currax

Pharmaceutical

Speakers Bureau

Pharmaceuticals

Phenomix

Biotechnology, pharmaceutical Advisor

Nutrition Education Education

Nestle Nutrition

Food and beverage

Co-Medical Director

Paradigm Pri-Med

Education

Faculty

Continuing medical education (CME) Education

CME Speaker

501C-6 / 501C-3 Organization+A69s

American Medical Association (AMA)

Association

Member

Senior Vice President of Weight Management

Pharmaceuticals

HIMS Company

Biotechnology

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Pharmaceutical

Eli Lilly (Zepbound)

Speakers Bureau

Product

Company

Type

Relationship

Board Member

Company Description

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Tiffany Lowe Clayton

Pharmaceutical

Eli Lilly

Speakers Bureau

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Provides a modern-day health coach certification integrating physical nutrition, mental health, and spirituality.

Pharmaceuticals

NovoNordisk

Biotechnology, pharmaceutical Speakers Bureau

Institute of Transformational Health and Wellness

Wellness consulting (No products sold)

Pharmaceuticals

Biotechnology, pharmaceutical

Product

Company

Type

Relationship

Board Member

Company Description

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Chris Weber

Pharmaceutical

Eli Lilly

Advisory Board

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.

Speakers Bureau - Obesity and Obesity/Healthcare Systems

Pharmaceuticals

NovoNordisk

Biotechnology, pharmaceutical

Bariatric care teams at Ascension in Wisconsin provide bariatric surgery and medically supervised weight loss. Healthcare

Ascension Wisconsin Bariatric Services

Healthcare

Medical Director

Founded in 2017 with the goal of improving the wellness, health, and contentment of individuals and the community, Refine Wellness Consulting is pleased to join with the millions already working towards this goal and to do so with a unique, convenient, and person-centered design.

Healthcare- online strength and conditioning coaching

Healthcare

Refine Wellness Consulting

Owner

Product

Company

Type

Relationship

Board Member

Company Description

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Speaker (Zepbound), Advisory Board

Karli Burridge

Pharmaceutical

Eli Lilly

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health. The Obesity Society (TOS) is the leading scientific society dedicated to the study of obesity. Illinois Obesity Society is a group of health care professionals dedicated to improving the treatment of Obesity in Illinois. The vision and mission of this organization is to strive to represent PAs practicing or interested in obesity medicine so as to maximize the benefit of their services to the public, ensure their professional growth, personal excellence, and recognition to support their efforts to enable them to improve the quality, accessibility, and cost effectiveness of patient-centered health care to patients with obesity. Gaining Health provides clinicians with the tools, resources, and support needed to develop evidence-based obesity management programs efficiently. Founded in 2020, it has assisted hundreds of clinicians in establishing successful programs, ultimately improving patient care and outcomes in obesity management.

Pharmaceuticals

NovoNordisk

Biotechnology, pharmaceutical Advisory Board

Speaker (Qsymia), Advisory Board

Pharmaceutical

Vivus

Biopharmaceutical

501C-6 / 501C-3 Organizations

The Obesity Society (TOS)

Association

Member

501C-6 / 501C-3 Organizations

Illinois Obesity Society

Association

Member

Healthcare

PAs in Obesity Medicine

Association

President

True Health Solutions, LLC, dba Gaining Health.

Healthcare

Health Care

Owner, Founder, President

Product

Company

Type

Relationship

Board Member

Company Description

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Courtney Younglove

Pharmaceutical

Eli Lilly

Focus Group (Zepbound)

A local organization of providers working in the Obesity Medicine space Healthcare

Healthcare

Midwest Obesity Society

Member

sole owner of a private practice Obesity Medicine clinic

Healthcare

Heartland Weight Loss

Healthcare

Medical director of the clinic

Journeys is a digital platform designed to help individuals improve their metabolic health. WellMi is a point solution for obesity that is currently being built and is designed to provide self-funded employers with a high-quality solution to tackle obesity. Redesign Health Inc. operates as a health care company. The Company focuses on developing technologies, tools, and insights to improve surgical outcomes for patients, as well as co develop, launch, and scale new businesses that tackle the most pressing issues in healthcare. Retool isa grant-funded study organized by several providers at the University of Kansas.

Biotechnology

Journeys Metabolic.

Healthcare Tech Startup

Chief Medical Officer

Biotechnology

WellMi

Healthcare Tech

Cofounder

Healthcare Technology

Redesign Health

Biotechnology, Medical

Advisor

Education

Retool

Research and education

Involved in the study

Action Item for Approval of the Consent Agenda and Supporting Documents Section: - Read and be prepared to vote on the consent agenda items

Rules of Order Policy Board Approved September 2017

Rules of Order for Board Meetings Quorum: Our bylaws state that a quorum is present if the majority of the board is present.

Order of the day: Each meeting will have an agenda which will include points to discuss, old business and new business. The leader of the meeting is referred to as the “Chair.” This may be the chairman of the board, the president, or the highest-ranking officer present at the meeting. Items to discuss: All board members may submit items to discuss. These items must be submitted at least 2 weeks prior to the scheduled meeting. Items must be submitted electronically as editable Microsoft word documents. Items must include: the person (or persons, committee, etc.) introducing the item and the date of submission. Items should be marked as informational items (board updates), discussion items (not asking for action), or action items. For action items, the specific action being requested by the board should be clearly indicated. Late items: From time to time, items of critical importance may need to be introduced within 2 weeks of the board meeting. These items will be marked in the board book as “Late” and will only be discussed after a majority vote of the board to discuss the item. Motions: Introducing a main motion 1) The chair may call on the person responsible for the next order of business. Or, when no one else has the floor, a board member may address the chair by proper title. After recognition by the chair, the board member may make a motion. 2) To make a motion, state, “I move that…,” and state your motion. For example, “I move that we discuss item #4 regarding updating our travel policy…” Regarding the above items of business, the person who introduced the item of business and who’s name appears on the item of business should introduce the motion. 3) Another member may second your motion. A second simply means that the motion should be discussed. If the motion is not seconded, it is not up for discussion. It is not lost, as there has been no vote. 4) Only if there is a second, the chair states “It has been moved and seconded that…” (state the motion). “Is there any discussion?” 5) Only one main motion may be on the floor at a time. Discussing a motion 1) All speaking points should be limited to 3 minutes. This will be enforced with a timer, and an OMA staff person will be designated to monitor the timer. A different time limit (or no time limit) may also be used if requested by a majority of the quorum, either for a single item of business, or for the entire meeting. 2) The member who made the motion is entitled to speak to it first. 3) Every member may speak to the motion. Only the motion at hand should be spoken either for or against. Each member should clearly state whether they are speaking for or against the motion. 4) A person may not speak against their own motion (however, they can vote against their own motion). 5) All discussion should be directed towards the motion. Avoid using a person’s name during the debate. 6) All questions should be directed to the chair. 7) Each member may only speak to the motion twice; however, asking a question or a brief suggestion does not count as that person’s debate.